Article ; Online: Reduction of daily-use parabens and phthalates reverses accumulation of cancer-associated phenotypes within disease-free breast tissue of study subjects
Chemosphere. 2023 Feb. 04, p.138014-
2023 , Page(s) 138014–
Abstract: Estrogenic overstimulation is carcinogenic to the human breast. Personal care products (PCPs) commonly contain xenoestrogens (XE), such as parabens and phthalates. Here, we identified the adverse effects of persistent exposure to such PCPs directly ... ...
Abstract | Estrogenic overstimulation is carcinogenic to the human breast. Personal care products (PCPs) commonly contain xenoestrogens (XE), such as parabens and phthalates. Here, we identified the adverse effects of persistent exposure to such PCPs directly within human estrogen responsive breast tissue of subjects enrolled in a regimen of reduced XE use (REDUXE). Pre- and post-intervention fine needle aspirates (FNAs) of the breast were collected from healthy volunteers who discontinued the use of paraben and phthalate containing PCPs over a 28 d period. Based on high-dimensional gene expression data of matched FNA pairs of study subjects, we demonstrate a striking reversal of cancer-associated phenotypes, including the PI3K-AKT/mTOR pathway, autophagy, and apoptotic signaling networks within breast cells of REDUXE compliant subjects. These, and other altered phenotypes were detected together with a significant reduction in urinary parabens and phthalate metabolites. Moreover, in vitro treatment of paired FNAs with 17β-estradiol (E2), displayed a ‘normalizing’ impact of REDUXE on gene expression within known E2-modulated pathways, and on functional endpoints, including estrogen receptor alpha: beta ratio, and S-phase fraction of the cell cycle. In a paradigm shifting approach facilitated by community-based participatory research, REDUXE reveals unfavorable consequences from exposure to XEs from daily-use PCPs. Our findings illustrate the potential for REDUXE to suppress pro-carcinogenic phenotypes at the cellular level towards the goal of breast cancer prevention. |
---|---|
Keywords | apoptosis ; autophagy ; breast neoplasms ; breasts ; carcinogenicity ; cell cycle ; cooperative research ; estrogen receptors ; estrogens ; gene expression ; humans ; metabolites ; phthalates ; xenoestrogens ; Endocrine disruption ; Biomarkers ; Nonmalignant breast tissue ; Paired human samples ; Pan-cancer pathways ; PCP ; XE ; REDUXE ; FNA ; E2 ; Pg ; SHBG ; REDUXExE2 ; DEG |
Language | English |
Dates of publication | 2023-0204 |
Publishing place | Elsevier Ltd |
Document type | Article ; Online |
Note | Pre-press version |
ZDB-ID | 120089-6 |
ISSN | 1879-1298 ; 0045-6535 ; 0366-7111 |
ISSN (online) | 1879-1298 |
ISSN | 0045-6535 ; 0366-7111 |
DOI | 10.1016/j.chemosphere.2023.138014 |
Database | NAL-Catalogue (AGRICOLA) |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2540: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.